Clinical Trial Update: Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment [NA]

View source ↗

Summary

Clinical trial update noting an active-not-recruiting study sponsored by CathWorks evaluating the FFRangio coronary physiology assessment during percutaneous co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: CathWorks Ltd. | Conditions: Percutaneous Coronary Intervention | NA | Status: ACTIVE_NOT_RECRUITING